Skyrizi (risankizumab)
pCPA File Number:
22367
Negotiation Status:
Concluded with an LOI
Indication(s):
For the treatment of adults with moderately to severely active Crohn's disease
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
SR0767
pCPA Engagement Letter Issued:
Negotiation Process Concluded: